The pharmaceutical research community has had a longstanding guideline that for
experimental therapeutic preclinical studies at least six animals are required for each data …

The process of drug discovery and development requires enormous resources and time,
with increasing cost for new drug development. Molecular imaging techniques have …

Molecular imaging enables noninvasive characterization, quantification and visualization of
biological and pathological processes in vivo at cellular and molecular level. It plays an …

The discovery and development of a biologically active molecule with therapeutic properties
is an increasingly complex task, highly unpredictable at the early stages and frequently …

Drug discovery and development is a time-consuming and costly process, which may take
approximately 15 years to advance from laboratory discovery to FDA approval and require …

While economic, scientific and regulatory questions still need to be answered, imaging
technologies have the potential to increase efficiencies in many areas of drug research. This …

Targeted drugs hold great promise for the treatment of malignant tumors; however, there are
several challenges for efficient evaluation of these drugs in preclinical and clinical studies …

Molecular imaging can allow the non-invasive assessment of biological and biochemical
processes in living subjects. Such technologies therefore have the potential to enhance our …

The role of medical imaging in the preclinical, pharmaceutical environment has entered a
growth phase in the drug discovery setting due to at least three main factors:(i) improved …

Molecular imaging is the visualization, characterization, and measurement of biological
processes at the molecular and cellular levels in humans and other living systems. In the …